🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Toronto surg onc… past, present and future! Such a privilege to be part of this program!

PROSPECT trial published! In sphincter persevering MRF- T2N1, T3N0-1 patients, FOLFOX noninferior to chemoradiotherapy with LRFS/DFS. Although avoiding CRT is a great option, these pts may also be treated w direct to surgery approach. ? Overtreatment? nejm.org/doi/full/10.10…

Excellent course taught by incredible faculty. Thank you to Jason W Denbo and Daniel Anaya Moffitt Hepatobiliary for hosting the 3rd annual Complex HPB Surgery course for CGSO fellows and to guest faculty Syed A. Ahmad Alexandra Gangi, MD mariano gimenez 🙏🏽

Long awaited PROSPECT trial presented ASCO last month... But, what does this mean for tx of locally advanced #rectalcancer in 2023 and how might this be context dependent? Read more in our accompanying editorial NEJM nejm.org/doi/full/10.10…

Our new fellow class is here! Heart and soul of our hospital! What a privilege to work with such amazing people.

Everyday is #WomenInMedicine month with these extraordinary athenas Memorial Sloan Kettering Cancer Center #surgonc fellowship! Vivian E. Strong, MD Alice Wei Aimee Crago, M.D. Charlotte Ariyan #maria_widmar

Just published in The Lancet Oncology ! In this essay, Chris Booth and I discuss how 25 years of “innovation” in the treatment of metastatic pancreatic cancer has barely budged the survival rates for this still lethal disease. Just moving the goalposts doesn’t mean patient outcomes

Opinion: Our clinical trials system is failing Canadians with cancer theglobeandmail.com/opinion/articl…

Still time to register! Cdn General Surgeons CAGS Residents CSSO ASCRS_1 Society of Surgical Oncology

A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma | Nature Cancer nature.com/articles/s4301…

"A national cancer clinical trial system, with education and training, streamlined ethics, and support for initiatives to address genomic testing for trials and reduce regulatory and other trial burdens, would be an investment in our health-care system"🇨🇦 thestar.com/opinion/contri…

Support these talented surgeons riding 2 help our patients & support cancer research Cycle for Survival Drs. Farrow, Foster, Saadat & Liu Memorial Sloan Kettering Cancer Center: Nellie: secure2.convio.net/mskcc/site/TR/… Deshka: secure2.convio.net/mskcc/site/TR/… Lily: secure2.convio.net/mskcc/site/TR/… Marion: secure2.convio.net/mskcc/site/TR/…

Looking forward to this event - thanks for the invite Techniques in Coloproctology Journal Join us to learn about conducting, reading, writing, and reviewing systematic reviews and meta-analyses CAGS Residents Cdn General Surgeons ebrsonline

Great fun! Thank you Rodrigo O Perez and Techniques in Coloproctology Journal for the invite!

Proud to share this major collaborative effort with everyone. I will share my thanks at the end of this thread. But first, I want to share some key points to take away from this paper on #cancer risk due to #CDH1...

Congrats to the graduating fellows ⁦Memorial Sloan Kettering Cancer Center⁩!!! Huge honor to train alongside this crew - looking forward to our 2nd year! ⁦Michael D’Angelica⁩ Alice Wei ⁦Fahima Dossa, MD PhD⁩ ⁦Lily Saadat⁩ ⁦Nellie Farrow⁩ ⁦Josh Jolissaint⁩ ⁦Pablo Lozano Lominchar⁩

It’s out! This guideline JAMA Oncology #desmoid reflects our multidisciplinary global collaboration, highlights new treatment strategies &importance of quality of life. Thanks Bernd Kasper, Alessandro Gronchi, pts, all. Current Management of Desmoid Tumors: A Review. pubmed.ncbi.nlm.nih.gov/38900421/

TOPGEAR: In a trial comparing chemotherapy and preoperative chemoradiotherapy with perioperative chemotherapy in patients with resectable gastric or GE junction cancer, no significant difference in overall survival was noted. Full trial results: nej.md/4gg4gqv #ESMO24

Kicking off #CTOS2024 with TARPSWG this morning. Marco Fiore, MD, FACS, FEBSh leading the discussion on 🌎 collaboration to standardize RPS terminology 👏👏 #CTOSTweeTOS

The TARPSWG meeting kicks off in beautiful Tampa! Great to reconnect with friends & colleagues from🌎🌍🌏. Amazing overview of the group’s achievements over the past year by Alessandro Gronchi truly incredible how far we’ve come! #sarcoma #retroperitonealsarcoma